Metsera has no products on the market, but it is developing oral and injectable treatments.
Novo Nordisk CFO outlines ‘ultimate defense’ against stock downgrades and lawsuits to retain weight-loss crown
November 6, 2025
Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic
November 6, 2025
Merck snags Chinese obesity drug in nearly $2 billion deal
Metsera accepts Pfizer's $10 billion bid in ongoing M&A battle
The Multi-Billion-Dollar Battle For Metsera
Novo Nordisk again raises bid in battle for obesity start-up Metsera
Weight-loss drug makers announce pricing agreement with Trump
Pfizer übertrumpft Novo in Bieterschlacht um Metsera
Más tensión en Novo Nordisk: rebaja previsiones en plena guerra con Pfizer por la ‘start-up’ de moda en el adelgazamiento
Trump Says Obesity Drugmakers Will Cut GLP-1 Prices—Medicare Will Cover Some Costs
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
Pfizer vince la guerra con Novo Nordisk e acquisisce Metsera, startup di farmaci dimagranti
Healthy Returns: Novo Nordisk boosts the case for its upcoming obesity pill with additional data
